Orange Book product · Generic (ANDA)
CETRORELIX ACETATE
CETRORELIX ACETATE
At a glance
Apr 16, 2024
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 16, 2024
2 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
CETRORELIX ACETATE
Strength
EQ 0.25MG BASE/VIAL
Dosage form
POWDER
Route
SUBCUTANEOUS
TE code
AP
Application
ANDA 217776
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CETRORELIX ACETATE
- 2000CETROTIDEBrand (NDA)
NDA 021197 · EMD SERONO INC
- 2026CETRORELIX ACETATEGeneric (ANDA)
ANDA 218740 · EPIC PHARMA LLC
- 2025CETRORELIX ACETATEGeneric (ANDA)
ANDA 218061 · XIROMED
- 2024CETRORELIX ACETATEGeneric (ANDA)
ANDA 218150 · GLAND
- 2024CETRORELIX ACETATEGeneric (ANDA)
ANDA 214540 · LIVZON GRP
- 2022CETRORELIX ACETATEGeneric (ANDA)
ANDA 215737 · TEVA PHARMS INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
